Fertility intentions following testing for a BRCA1 gene mutation

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 5, 2004, Pages 733-740

  Smith, Ken R ^a   Ellington, Lee ^a   Chan, Anna Y ^b   Croyle, Robert T ^c   Botkin, Jeffrey R ^a  

^a UNIVERSITY OF UTAH   (United States)

^b U S CENSUS BUREAU   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; FAMILY PLANNING; FEMALE; FERTILITY; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONCOGENE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BREAST NEOPLASMS; COHORT STUDIES; DECISION MAKING; FEMALE; FERTILITY; FOLLOW-UP STUDIES; GENES, BRCA1; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PROBABILITY; RISK FACTORS; SEX FACTORS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 2942580730     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Codori A-M, Brandt J. Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet 1994;54:174-84.
2. Codori A-M, Slavney PR, Young C, Miglioretti DL, Brandt J. Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol 1997;16:36-50.
3. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997;16:63-72.
4. Lerman C, Hughes C, Lemon SJ, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998;16:1650-4.
5. Marteau TM, Dundas R, Axworthy D. Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychol 1997;16:51-62.
6. Smith KR, West JA, Croyle RT, Botkin JR. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers & Prev 1999 Apr;8(4 Pt 2):385-92.
7. Tibben A, Timman R, Bannink EC, Duivenvoorden HJ. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 1997;16:20-35.
8. Wiggins S, Whyte P, Huggins M, et al. The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 1992;327:1401-5.
9. Zick CD, Smith KR, Mayer RN, Botkin JR. Genetic testing, adverse selection, and the demand for life insurance. Am J Med Genet 2000;93:29-39.
10. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer: what are the risks? What are the choices? JAMA 1993;269:1975-80.
11. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266(5182):66-71.
12. Easton DF, Ford D, Bishop DT and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56:265-71.
13. Devilee P. BRCA1 and BRCA2 testing: weighing the demand against the benefits. Am J Hum Genet 1999;64:943-8.
14. Easton D. Breast cancer genes-what are the real risks? Nat Genet 1997;16:210-1.
15. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003 May;72(5):1117-30.
16. Thompson D, Easton DF. Breast cancer linkage consortium cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002 Sep 18;94(18):1358-65.
17. Bonadona V, Saltel P, Desseigne F, et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers & Prev 2002;11:97-104.
18. Kessler S. Psychological aspects of genetic counseling: VI. A critical review of the literature dealing with education and reproduction. Am J Med Genet 1989;34:340-53.
19. Nance MA, Sevenich EA, Schut LJ. Knowledge of genetics and attitudes toward genetic testing in two hereditary ataxia (SCA1) kindreds. Am J Med Genet 1994;54:242-8.
20. Johnson WG, Lucel PR, Chatkupt S, et al. Reduced fecundity in male ALS gene-carriers. Am J Med Genet 1995;59:149-53.
21. Pridmore SA. Relative fertility of unaffected siblings of the Huntington's disease families in Tasmania. Med J Aust 1990;153:588-9.
22. Morrison PJ, Johnston WP, Nevin NC. The epidemiology of Huntington's disease in Northern Ireland. J Med Genet 1995;32:524-30.
23. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JGM, Niermeijer MF. Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands. J Med Genet 2000;37(11):883-4.
24. Botkin JR, Croyle RT, Smith KR, et al. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst 1996;88:872-82.
25. Goldgar D, Fields P, Lewis CM. A large kindred with the 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 1994;86:200-9.
26. Baty B, Venne V, McDonald J, Croyle R, Botkin J. Genetic counseling protocols for BRCA1 testing. J Genet Counsel 1997;6:223-44.
27. Horowitz M, Wilner N, Alvarez W. The Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-18.
28. Zilberg NJ, Weiss DD, Horowitz MJ. Impact of Event Scale: a cross-sectional validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol 1982;50:407-14.
29. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986 Mar; 42(1):121-30.
30. Motulsky A. Impact of genetic manipulation on society and medicine. Science 1983;219:135-40.
31. Annas E, editor. Gene mapping: using law and ethics as guides. New York: Oxford University Press, 1992.
32. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG. Assessing genetic risks: implications for health and social policy. Washington DC: National Academy Press; 1994.
33. Lynch HT, Lemon SJ, Durham C, et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 1997;79(11):2219-28.
34. Richards CS, Ward PA, Roa BB, et al. Screening for 185delAG in the Ashkenazim. Am J Hum Genet 1997;60(5):1085-98.
35. Botkin JR, Smith KR, Croyle RT, et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 2003 Apr 30;118A(3):201-9.
36. Smith KR, Zick CD, Mayer RN, Botkin JR. Voluntary disclosure of BRCA1 mutation tests results. Genet Test 2002;6:89-93.